Alpha1-proteinase Inhibitor (human)
Generic Name: alpha1-proteinase inhibitor (human)
Brand Names:
Prolastin-c Liquid
Dosage form: INJECTION, SOLUTION. Route: INTRAVENOUS. Active ingredients: .ALPHA.1-PROTEINASE INHIBITOR HUMAN (1000 mg/20mL). Category: BLA.
Overview
Dosage form: INJECTION, SOLUTION. Route: INTRAVENOUS. Active ingredients: .ALPHA.1-PROTEINASE INHIBITOR HUMAN (1000 mg/20mL). Category: BLA.
Dosage
Available as injection, solution for intravenous use.
Related Medications
Abrotanum (artemisia Abrotanum), Aethusa Cynapium, Baptisia Tinctoria, Cicuta Virosa, Cuprum Metallicum, Mezereum, Bufo Rana, Lac Materna Humanum, Saccharum Officinale, Serotonin (hydrochloride), Alumina, Calcarea Phosphorica, Candida Albicans, Carcinosin, Helium, Lac Caninum, Mercurius Solubilis, Natrum Muriaticum, Sulphur, Thuja Occidentalis, Formalinum, Morbillinum
abrotanum (artemisia abrotanum), aethusa cynapium, baptisia tinctoria, cicuta virosa, cuprum metallicum, mezereum, bufo rana, lac materna humanum, saccharum officinale, serotonin (hydrochloride), alumina, calcarea phosphorica, candida albicans, carcinosin, helium, lac caninum, mercurius solubilis, natrum muriaticum, sulphur, thuja occidentalis, formalinum, morbillinum
Non-Standardized Fungal Allergenic Extract [EPC]
INDICATIONS: May temporarily relieve symptoms of dullness with gastro-intestinal discomfort, feeling unconnected to others, and minor symptoms following vaccination.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Anakinra
anakinra
Interleukin-1 Receptor Antagonist [EPC]
11 DESCRIPTION KINERET (anakinra) is a recombinant , nonglycosylated form of the human interleukin-1 receptor antagonist (IL-1Ra). KINERET differs from native human IL-1Ra in that it has the addition of a single methionine residue at its amino terminus. KINERET consists of 153 amino acids and has a molecular weight of 17.3 kilodaltons. It is produced by recombinant DNA technology using an E coli bacterial expression system.
Chlorotrianisene
chlorotrianisene
Manufactured by SANOFI AVENTIS US. Dosage form: CAPSULE. Route: ORAL. Active ingredients: CHLOROTRIANISENE (25MG). Application: NDA011444.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.